242 related articles for article (PubMed ID: 23928100)
1. Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.
Fox BA; Sanders KL; Chen S; Bzik DJ
Trends Parasitol; 2013 Sep; 29(9):431-7. PubMed ID: 23928100
[TBL] [Abstract][Full Text] [Related]
2. Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity.
Fox BA; Sanders KL; Rommereim LM; Guevara RB; Bzik DJ
PLoS Genet; 2016 Jul; 12(7):e1006189. PubMed ID: 27447180
[TBL] [Abstract][Full Text] [Related]
3. Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment.
Baird JR; Fox BA; Sanders KL; Lizotte PH; Cubillos-Ruiz JR; Scarlett UK; Rutkowski MR; Conejo-Garcia JR; Fiering S; Bzik DJ
Cancer Res; 2013 Jul; 73(13):3842-51. PubMed ID: 23704211
[TBL] [Abstract][Full Text] [Related]
4. Nonreplicating, cyst-defective type II Toxoplasma gondii vaccine strains stimulate protective immunity against acute and chronic infection.
Fox BA; Bzik DJ
Infect Immun; 2015 May; 83(5):2148-55. PubMed ID: 25776745
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication.
Gigley JP; Fox BA; Bzik DJ
J Immunol; 2009 Jan; 182(2):1069-78. PubMed ID: 19124750
[TBL] [Abstract][Full Text] [Related]
6. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.
Charest H; Sedegah M; Yap GS; Gazzinelli RT; Caspar P; Hoffman SL; Sher A
J Immunol; 2000 Aug; 165(4):2084-92. PubMed ID: 10925293
[TBL] [Abstract][Full Text] [Related]
7. Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations.
Sanders KL; Fox BA; Bzik DJ
Cancer Immunol Res; 2015 Aug; 3(8):891-901. PubMed ID: 25804437
[TBL] [Abstract][Full Text] [Related]
8. A uracil auxotroph Toxoplasma gondii exerting immunomodulation to inhibit breast cancer growth and metastasis.
Xu LQ; Yao LJ; Jiang D; Zhou LJ; Chen M; Liao WZ; Zou WH; Peng HJ
Parasit Vectors; 2021 Dec; 14(1):601. PubMed ID: 34895326
[TBL] [Abstract][Full Text] [Related]
9. Long-term immunity to lethal acute or chronic type II Toxoplasma gondii infection is effectively induced in genetically susceptible C57BL/6 mice by immunization with an attenuated type I vaccine strain.
Gigley JP; Fox BA; Bzik DJ
Infect Immun; 2009 Dec; 77(12):5380-8. PubMed ID: 19797073
[TBL] [Abstract][Full Text] [Related]
10. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
Khan IA; Casciotti L
J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393
[TBL] [Abstract][Full Text] [Related]
11.
Chen J; Liao W; Peng H
Front Cell Infect Microbiol; 2022; 12():959300. PubMed ID: 36118042
[TBL] [Abstract][Full Text] [Related]
12. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
[TBL] [Abstract][Full Text] [Related]
13. Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge.
Baird JR; Byrne KT; Lizotte PH; Toraya-Brown S; Scarlett UK; Alexander MP; Sheen MR; Fox BA; Bzik DJ; Bosenberg M; Mullins DW; Turk MJ; Fiering S
J Immunol; 2013 Jan; 190(1):469-78. PubMed ID: 23225891
[TBL] [Abstract][Full Text] [Related]
14. A potential cure for tumor-associated immunosuppression by Toxoplasma gondii.
Lotfalizadeh N; Sadr S; Morovati S; Lotfalizadeh M; Hajjafari A; Borji H
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1963. PubMed ID: 38109851
[TBL] [Abstract][Full Text] [Related]
15. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
[TBL] [Abstract][Full Text] [Related]
16. Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.
Zorgi NE; Galisteo AJ; Sato MN; do Nascimento N; de Andrade HF
Med Microbiol Immunol; 2016 Aug; 205(4):297-314. PubMed ID: 26732075
[TBL] [Abstract][Full Text] [Related]
17. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection.
Wilson DC; Matthews S; Yap GS
J Immunol; 2008 May; 180(9):5935-45. PubMed ID: 18424713
[TBL] [Abstract][Full Text] [Related]
18. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.
Chen J; Li ZY; Petersen E; Liu WG; Zhu XQ
Exp Parasitol; 2016 Mar; 162():18-23. PubMed ID: 26706605
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
Zhao Y; Huang B; Huang S; Zheng H; Li YQ; Lun ZR; Shen J; Wang Y; Kasper LH; Lu F
Parasitol Res; 2013 Sep; 112(9):3151-60. PubMed ID: 23783399
[TBL] [Abstract][Full Text] [Related]
20. Host resistance and immune deviation in pigeon cytochrome c T-cell receptor transgenic mice infected with Toxoplasma gondii.
Collazo CM; Miller C; Yap G; Hieny S; Caspar P; Schwartz RH; Sher A
Infect Immun; 2000 May; 68(5):2713-9. PubMed ID: 10768964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
